Marihuana smoking caused a significant increase in heart rate in 25 normal male volunteers. The degree of techycardia was significantly related to the dose of Many observers 6 , 7, 10 have noted a significant dose-related increase in pulse rate in subjects smoking marihuana. While studying the effects of marihuana on the electroencephalogram (EEG ) and on tests of perception and cognitive function, we observed premature ventricular contractions in 2 healthy subjects. A search of previous publications on marihuana revealed little detail about its cardiovascular effects. In view of the large number of
marihuana smokers of all ages and the increasing interest in possible therapeutic uses of marilmana, we thought it important to investigate more thoroughly its cardiovascular actions.
Materials and methods
This study was performed in two parts. In 1969, 10 subjects took part in a low dose (0.5 per cent 6.-9-tetrahydrocannabinol [THe]) marihuana study and then in a single-blind placebo (0 per cent .6.-9-THe) study. In early 1971, 15 different subjects took part in a high dose (2.9 per cent 6.-9-THe) marihuana study. All subjects were men between the ages of 21 and 33. All had smoked marihuana previously, but only 4 of 10 in the low-dose study and 2 of 15 in the high-dose study were daily users. One of the subjects in the high-dose study was able to tolerate a large dose (30 mg. ~-9-THC) with little change in his outward behavior or conversation. The other 14 subjects reported they were "as high or higher than ever before" during the highdose marihuana study.
The subjects received thorough medical histories, reviews of systems, and psychiatric and physical examinations. None had scores outside the normal range on the Minnesota Multiphasic Personality Inventory (MMPI). None had a history of heart disease or hypertension, nor did they have elevated blood pressure readings, irregularities of pulse, cardiac murmurs, abnormal electrocardiograms (ECG), or other evidence of cardiovascular disease on physical examination.
Marihuana was obtained from the National Institute of Mental Health. The first batch was shown by independent analysis\) to contain 0.5 per cent ~-9-tetrahydrocanna binoI. Subsequently, it was found to contain 0.2% ~-9-THC.t It was used for the low dose studies and arbitrarily assumed to contain 0.5 per cent during most of the study. A second batch of marihuana for the high dose study contained 2.9 per cent ~-9-THC.t All marihuana was administered as 300 mg. cigarettes which were smoked to the shortest possible butt. Butts were weighed to determine the approximate dose smoked. In the low-dose study, subjects smoked from 2 to 5 cigarettes. In the high-dose study, subjects were instructed to smoke until they were as high as they had ever been on marihuana and felt they could not smoke any more. This required from one to 4 cigarettes. Subjects were told to inhale deeply and to let none of the smoke appear in the exhaled °Dr. Monroe E. Wall Electrocardiograms of the 3 standard limb leads and the six chest leads were obtained in the supine position before and within 1f2 hour after finishing the marihuana in 8 subjects. In 2 of the subjects, ECG's were also obtained after singleblind administration of placebo extract marihuana on which the subjects felt subjectively high and also after exercise.
Blood pressure was measured at least three times before smoking marihuana to obtain a stable base line. It was recorded three times again within 1f2 hour after smoking. Diastolic pressure was recorded at the muming of the Korotkoff sound. The difference in means of the blood pressures before and after marihuana is reported as the change in blood pressure.
Pulse rate was recorded from a continuous polygraph record in those subjects who did not have complete ECG's. The change in pulse rate is the difference between a base-line rate and the highest rate obtained within one hour of smoking marihuana.
Results
Our experiments show that the increase in heart rate after smoking marihuana is dose related (Fig. 1) . The coefficient of correlation between logro dose and the increase in heart rate is 0.8 for which p < 0.001. One subject, a daily user of marihuana, seemed to be extremely tolerant of the psychic effects. However, his heart rate increased from 55 to 120 after a 30 mg. dose. The marihuana-induced tachycardia persists at least 90 minutes (Fig.  2) . The maximum heart rate was usually reached within 30 minutes after smoking the marihuana.
The systolic blood pressure was significantly elevated in subjects receiving more than 10 mg. of marihuana (p <0.01 on the Wilcoxin sign test for differences in related samples). The rise in systolic blood pressure appeared to be dose related, although . Dose-effect relationship of marihuana smoki~g on heart rate. Adult male volunteers were given various amounts of marihuana of varying 1l-9-THC content. The maximal increase in heart rate above control is given on the y axis and the total amount of 1l-9-THC in the cigarettes on the x axis. Each point represents an individual subject. The coefficient of correlation is 0.8 for which p <0.001. the coefficient of correlation was only 0.3 and the p value <0.10. The diastolic blood pressure was also significantly elevated after marihuana smoking (p <0.02 on the Wilcoxin test). For the diastolic pressure data the coefficient of correlation of the 10glo dose response curve was only 0.3. Systolic and diastolic blood pressure data are shown in Fig. 3 . The data from the single-blind placebo extract experiments showed no significant changes in heart rate or blood pressure. Fig. 4 shows selected portions of Leads I, II, and Vs of the ECG tracings, the baseline, placebo, post-15.3 mg. Ll-9-THC, and post-exercise results. Smoking marihuana tended to flatten T waves, especially in the chest leads, in many subjects, but T wave flattening was not a constant finding. T wave changes induced by exercise are more prominent than those induced by the marihuana SIT',oking. Two of 15 subjects in the high-dose study developed premature ventricular contractions ( PVC's). The PVC's occurred less than 1 per 25 beats after marihuana smoking but did not appear in control ECG rhythm strips of 1 to 2 minutes in length or on control polygraph recordings. Two of the PVC's from one of the subjects are shown in Fig. 5 . Besides the PVC's in 2 subjects and the tachycardia and frequent T wave flattening in others, no ECG changes were noted.
Discussion
Marihuana causes a significant increase in heart rate. 6 , 7, 10 Isbell and associates 4 and Hollister and associates 3 have shown that Ll-9-THC produces most of the psychic effects of marihuana and also the tachycardia. A recent report by Manno and associates 6 shows that the increased heart rate after marihuana is dose related. Our study also indicates a significant dose-re- During the control sessions (10 min. tracing) the subject never showed PVC's but did after taking 18.9 mg. of 2.9 per cent 6.-9-THC marihuana cigarettes. This particular record was taken one hour after smoking but the PVC's were seen on a polygraph record shortly after smoking as well.
sponse relationship between the 6.-9-THC dose and the increased heart rate. The coefficient of correlation of 0.8 indicates that about 63 per cent of the variance in heart rate is associated with the dose of 6.-9-THC in these experiments. Variability in heart rate response to a given dose could result from a number of factors. Calculation of the marihuana dosage on a milligram per kilogram basis did not reduce the variation in the data and therefore are not included as a separate table.
As indicated in the Material and Methods section, the effects of pyrolysis,4 the efficiency of absorption of smoke by the lungs, and escape of smoke from the burning cigarette were not calculated into the dose. The dose indicated in the figures is the maximum possible dose each subject could have smoked. However, we believe that the actual dose absorbed is proportional to the total dose-that is, that losses of 6.-9-THC were similar for all subjects in the study.
A third possible explanation for variability of response at a given dose is that some subjects were tolerant to marihuana." o However, the one subject able to smoke 30 mg. of A-9-THC without feeling as high as he had ever been did have an increase of 65 beats per minute even though he seemed able to talk and reason as well as before he smoked. Hence, tolerance does not seem to develop as easily to the cardiovascular actions of marihuana as to its psychic effects. This is being pursued in another study separating subjects into tolerant and nontolerant groups.
Anxiety-producing and sedative effects of marihuana do change the magnitude of the tachycardia. This mood induced by the dose of marihuana may account for most of the variability in heart rate for a given dose. One subject, who became panicky after a 25 mg. dose of A-9-THC, had a heart rate increase of 108. Another who became somnolent after 25 mg. had a heart rate increase of only 36.
Other investigators 3 , 4, 10 have noted variable blood pressure changes after marihuana smoking. With low doses of A-9-THC, we noted no significant changes in blood pressure. 9 At doses above 10 mg. we noted significant increases in both systolic and diastolic blood pressures. Whether the changes in blood pressure are dose related is difficult to say. The coefficients of correlation of blood pressure and log dose are low. The changes in blood pressure correlated better with tachycardia than with dose of .A-9-THC: for increase in heart rate versus increase in systolic pressure, r = 0.381, P <0.07.
Concerning changes in the electrocardiograms, we observed premature ventricular contractions in 2 of 15 subjects receiving 10 mg. or more of marihuana. The subjects themselves were unaware of them. Flattening of T waves was observed, especially in the chest leads, but this was neither a constant nOr a specific finding. That ECG changes are minor after marihuana agrees with the conclusions of the LaGuardia Study7 and the study by Hol-lister and associates. 3 The latter reported uniformly negative ECG's in patients who received large oral doses of A-9-THC or pyrahexyI. This difference might indicate that the effects were related to smoking rather than to a pharmacological effect of THC.
The mechanism of the cannabis tachycardia remains unclear. The PVC's we observed may implicate catecholamine release. However, dry mouth, suggesting an atropine-like effect, and conjunctival injection, suggesting a vasodilatory action, are also present. 'Ve attempted to produce a cannabis tachycardia in an unanesthetized dog paralyzed with decamethonium. After intravenous doses of A-9-THC from 0.32 to 3.2 mg. per kilogram we observed electroencephalographic slowing and also hypotension and bradycardia. Species differences in the cardiovascular effects and the augmentation of the tachycardia by anxiety and its reduction by sedation, suggest that the cannabis tachycardia is mediated through the central nervous system. Although no deaths have been reported from marihuana intoxication alone, 5 the tachycardia, hypertension, and PVC's it can produce indicate that marihuana should be used with caution by people with heart disease. Like nicotine and caffeine, marihuana may be a cause of PVC's in susceptible individuals. This was a relatively rare finding and may be due to smoking rather than to pure A-9-THC. The two susceptible subjects merely had a "before" control tracing which did not show PVC's but did "after." Further studies are clearly indicated, for marihuana smoke contains many other chemical substances.
The clinical significance of our finding is probably no greater than that for susceptible subjects now smoking tobacco and drinking caffeine-containing beverages. 
